PT  - JOURNAL ARTICLE
AU  - Lalli, Matthew A.
AU  - Chen, Xuhua
AU  - Langmade, S. Joshua
AU  - Fronick, Catrina C.
AU  - Sawyer, Christopher S.
AU  - Burcea, Lauren C.
AU  - Fulton, Robert S.
AU  - Heinz, Michael
AU  - Buchser, William J.
AU  - Head, Richard D.
AU  - Mitra, Robi D.
AU  - Milbrandt, Jeffrey
TI  - Rapid and extraction-free detection of SARS-CoV-2 from saliva with colorimetric LAMP
AID  - 10.1101/2020.05.07.20093542
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.07.20093542
4099  - http://medrxiv.org/content/early/2020/05/11/2020.05.07.20093542.short
4100  - http://medrxiv.org/content/early/2020/05/11/2020.05.07.20093542.full
AB  - Rapid, reliable, and widespread testing is required to curtail the ongoing COVID-19 pandemic. Current gold standard diagnostic assays are hampered by supply shortages in critical reagents including nasal swabs, RNA extraction kits, personal protective equipment (PPE), instrumentation, and labor. Here we present an approach to overcome these challenges with the development of a rapid colorimetric assay using reverse-transcription loop-mediated isothermal amplification (RT-LAMP) optimized on human saliva samples without an RNA purification step. We describe our optimizations of the LAMP reaction and saliva pre-treatment protocols that enabled rapid and sensitive detection of < 102 viral genomes per reaction in contrived saliva controls. We also observed high performance of this assay on a limited number of clinical saliva samples. While thorough validation on additional clinical samples will be needed before such an assay can be widely used, these preliminary results demonstrate a promising approach to overcome the current bottlenecks limiting widespread testing.Competing Interest StatementWashington University in St. Louis has filed patent applications regarding this technology on behalf of the inventors.Funding StatementThese studies were supported by donations to the WUSM COVID Research fund, the Department of Genetics and the McDonnell Genome Institute, and NIH grants P30 CA91842 and UL1 TR000448.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are contained within the paper.